Tubiana M, Henry-Amar M, van der Werf-Messing B, Henry J, Abbatucci J, Burgers M, Hayat M, Somers R, Laugier A, Carde P
Int J Radiat Oncol Biol Phys. 1985 Jan;11(1):23-30. doi: 10.1016/0360-3016(85)90358-x.
A multivariate analysis of the prognostic factors was carried out with a Cox model on 1,139 patients with clinical Stage I + II Hodgkin's disease included in three controlled clinical trials. The following indicators had been prospectively registered: age, sex, systemic symptoms, erythrocyte sedimentation rate (ESR), number and sites of involved lymph node areas, histologic type, clinical stage, pattern of presentation, results of staging laparotomy when performed, as well as the date and type of treatment. A linear logistic analysis showed that most of the indicators are interrelated. This emphasizes the necessity of a multivariate analysis in order to assess the independent influence of each of them. The two main prognostic indicators for relapse-free survival are systemic symptoms and/or ESR and number of involved areas. The only significant factor for survival after relapse is age. Sex has a small but significant influence on relapse-free survival. The relative influence of each indicator varies with the type of treatment and these variations may help in understanding the biologic significance of the indicators.
对纳入三项对照临床试验的1139例临床I + II期霍奇金病患者,采用Cox模型对预后因素进行多变量分析。以下指标已进行前瞻性记录:年龄、性别、全身症状、红细胞沉降率(ESR)、受累淋巴结区域的数量和部位、组织学类型、临床分期、表现模式、进行分期剖腹术的结果,以及治疗日期和类型。线性逻辑分析表明,大多数指标相互关联。这强调了进行多变量分析以评估每个指标独立影响的必要性。无复发生存的两个主要预后指标是全身症状和/或ESR以及受累区域数量。复发后生存的唯一显著因素是年龄。性别对无复发生存有微小但显著的影响。每个指标的相对影响因治疗类型而异,这些差异可能有助于理解指标的生物学意义。